Found: 21
Select item for more details and to access through your institution.
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern.
- Published in:
- Journal of Cutaneous Pathology, 2018, v. 45, n. 7, p. 504, doi. 10.1111/cup.13150
- By:
- Publication type:
- Article
Aberrant expression of FLI-1 in melanoma.
- Published in:
- Journal of Cutaneous Pathology, 2017, v. 44, n. 9, p. 790, doi. 10.1111/cup.12979
- By:
- Publication type:
- Article
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy.
- Published in:
- Journal of Cutaneous Pathology, 2017, v. 44, n. 2, p. 158, doi. 10.1111/cup.12858
- By:
- Publication type:
- Article
BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.
- Published in:
- Journal of Cutaneous Pathology, 2012, v. 39, n. 9, p. 821, doi. 10.1111/j.1600-0560.2012.01950.x
- By:
- Publication type:
- Article
Eruptive melanotic macules and papules associated with adenocarcinoma.
- Published in:
- Journal of Cutaneous Pathology, 2003, v. 30, n. 7, p. 463, doi. 10.1034/j.1600-0560.2003.00089.x
- By:
- Publication type:
- Article
Chemoprevention for Brain Metastases.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 1, p. 63, doi. 10.1007/s11912-011-0200-1
- By:
- Publication type:
- Article
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1359, doi. 10.1007/s00262-017-2030-y
- By:
- Publication type:
- Article
Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).
- Published in:
- 2006
- By:
- Publication type:
- journal article
Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
- Published in:
- Cancer (0008543X), 1999, v. 86, n. 11, p. 2252, doi. 10.1002/(SICI)1097-0142(19991201)86:11<2252::AID-CNCR12>3.0.CO;2-Q
- By:
- Publication type:
- Article
Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 10, p. 2583, doi. 10.1007/s00520-011-1359-6
- By:
- Publication type:
- Article
Metastasis of Ciliary Body Melanoma to the Contralateral Eye: A Case Report and Review of Uveal Melanoma Literature.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 8, p. 1205, doi. 10.1177/0091270010381499
- By:
- Publication type:
- Article
Case of vemurafenib-induced Sweet's syndrome.
- Published in:
- Journal of Dermatology, 2014, v. 41, n. 9, p. 817, doi. 10.1111/1346-8138.12430
- By:
- Publication type:
- Article
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article